Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

Lindsey R. Baden, Hong‐Van Tieu, Hanneke Schuitemaker et al.|The Lancet HIV|2020

Cited by 91